Craft

IceCure Medical

Stock Price

$0.8

2024-10-29

Market Capitalization

$43.3 M

2024-10-29

Revenue

$3.4 M

FY, 2025

IceCure Medical Summary

Company Summary

Overview
IceCure Medical is manufacturer of medical devices. It provides advance treatment of cancerous tumors, breast lesions, solution for the treatment of benign and malignant breast tumours, renal, lung, and bone cancer, and more.
Type
Public
Status
Active
Founded
2006
HQ
Caesarea, IL | view all locations
Website
https://icecure-medical.com
Cybersecurity rating
Sectors

Key People

  • Ron Mayron

    Ron Mayron, Chairman of the Board

    • Eyal Shamir

      Eyal Shamir, CEO

      • Shay Levav

        Shay Levav, VP RA/QA & Clinical Applications

        LocationsView all

        1 location detected

        • Caesarea, Haifa District HQ

          Israel

          7 Ha’Eshel St., PO Box 316

        IceCure Medical Financials

        Summary Financials

        Revenue (FY, 2025)
        $3.4M
        Gross profit (FY, 2025)
        $1.4M
        Net income (FY, 2025)
        ($15.1M)
        Cash (FY, 2025)
        $8.9M
        EBIT (FY, 2025)
        ($15.1M)

        Footer menu